Clovis Oncology (NASDAQ:CLVS) Earnings Information
Clovis Oncology last announced its earnings results on February 22nd, 2021. The biopharmaceutical company reported ($1.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.76) by $0.26. Clovis Oncology has generated ($7.60) earnings per share over the last year. Clovis Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 4th, 2021 based off prior year's report dates.
Clovis Oncology Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Clovis Oncology (NASDAQ:CLVS) Earnings Estimates
2021 EPS Consensus Estimate: ($2.91)
2022 EPS Consensus Estimate: ($1.98)
Clovis Oncology (NASDAQ CLVS) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)